Therapeutic advances in gastroenterology · 2025
Overtreatment in colorectal cancer prevention: comparison between surgical and endoscopic treatment of benign colonic polyps.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sala-Miquel Noelia, Medina-Prado Lucía, Mangas-Sanjuan Carolina, Baile-Maxía Sandra, Alenda Cristina, Madero-Velázquez Lucía, Ruiz-Gómez Francisco A, Serrano Eva, Santana Enrique, Ausina Victor, Sáez-Rico María, Zapater Pedro, Martínez-Sempere Juan, Jover Rodrigo
Аннотация
BACKGROUND: The growing number of premalignant colonic lesions undergoing surgical treatment can lead to increased overtreatment.
OBJECTIVES: We assessed the magnitude of overtreatment by comparing rates of adverse events related to surgical and endoscopic treatment of complex benign polyps.
DESIGN: This was a single-center retrospective study conducted at a tertiary care hospital.
METHODS: This study included patients with benign colonic lesions treated surgically during 2005-2021 and compared with a cohort with complex lesions (Size, Morphology, Site, and Access (SMSA) ⩾3) treated endoscopically during 2018-2022. Adverse events, need for reintervention, mortality, and length of hospital stay were compared using propensity score (PS)-matching analysis. The cohorts were matched 1:1 with adjustment for sex, age, SMSA, and size as covariates. Surgical and endoscopic adverse events were described using the Clavien-Dindo (surgical group) and AGREE (endoscopic group) classifications.
RESULTS: Of 240 included patients, PS matching yielded 71 pairs. Adverse events were more frequent with surgical treatment (odds ratio (OR) 3.27; 95% confidence interval (CI) 1.59-6.71), as were severe adverse events (OR 7.5; 95% CI 2.1-27.0), need for reintervention (OR 25.6; 95% CI 3.3-200.0), and mean length of hospital stay (10 vs 0 days, p < 0.001). One (1.4%) patient in the surgical group and none in the endoscopic group died (p = 0.39).
CONCLUSION: An excess of severe adverse events with surgical treatment of complex benign polyps reflects overtreatment. Adequate pathways must be established for referral of these lesions for endoscopic treatment.
OBJECTIVES: We assessed the magnitude of overtreatment by comparing rates of adverse events related to surgical and endoscopic treatment of complex benign polyps.
DESIGN: This was a single-center retrospective study conducted at a tertiary care hospital.
METHODS: This study included patients with benign colonic lesions treated surgically during 2005-2021 and compared with a cohort with complex lesions (Size, Morphology, Site, and Access (SMSA) ⩾3) treated endoscopically during 2018-2022. Adverse events, need for reintervention, mortality, and length of hospital stay were compared using propensity score (PS)-matching analysis. The cohorts were matched 1:1 with adjustment for sex, age, SMSA, and size as covariates. Surgical and endoscopic adverse events were described using the Clavien-Dindo (surgical group) and AGREE (endoscopic group) classifications.
RESULTS: Of 240 included patients, PS matching yielded 71 pairs. Adverse events were more frequent with surgical treatment (odds ratio (OR) 3.27; 95% confidence interval (CI) 1.59-6.71), as were severe adverse events (OR 7.5; 95% CI 2.1-27.0), need for reintervention (OR 25.6; 95% CI 3.3-200.0), and mean length of hospital stay (10 vs 0 days, p < 0.001). One (1.4%) patient in the surgical group and none in the endoscopic group died (p = 0.39).
CONCLUSION: An excess of severe adverse events with surgical treatment of complex benign polyps reflects overtreatment. Adequate pathways must be established for referral of these lesions for endoscopic treatment.